跳至主要内容
临床试验/NCT07080138
NCT07080138尚未招募不适用

Research on the Psychological Status of Patients With HIV-1 Infection

Shanxi Bethune Hospital0 个研究点目标入组 500 人开始时间: 2025年8月1日最近更新:
干预措施
相关药物

试验速览

阶段
不适用
状态
尚未招募
入组人数
500
主要终点
The prevalence of AO among different treatment strategies

研究概览

简要总结

The goal of this observational study is to investigate the neuropsychological states of People Living With HIV(PLWH), the prevalence of social and psychological stress adaptation overload and poor episodic memory in PLWH. The main questions it aims to observe are: to observe the prevalence of psychopathic states in PLWH with different viral loads and to compare the effects of different treatments on the prevalence of psychopathic states in PLWH. It is helpful to understand the mental health burden faced by PLWH in China, to improve clinicians' awareness of PLWH's mental and psychological state, and formulate targeted psychological support, treatment and nursing programs.

详细描述

Our research is a prospective cohort of PLWH, mainly observing the differences in the prevalence of AO among different treatment strategies; Secondly, observe: ① The changes of neuropsychological symptoms such as newly diagnosed PLWH, AO, and Poor EM compared with the baseline; ② Changes in neuropsychological symptoms such as PLWH, AO, and Poor EM after treatment with different treatment regimens compared to the baseline; ③ For PLWH at different stages, after half a year of treatment, the changes of neuropsychological symptoms such as PLWH, AO, and Poor EM compared with the baseline; ④ Changes in Interpersonal Stress, Work Stress and Daily Stress conditions of PLWH compared with the baseline.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis: PLWH can be diagnosed if one of the following three items is met according to the Chinese AIDS Diagnosis and Treatment Guidelines (2021):
  • ① HIV antibody screening test positive and HIV supplementation test positive (antibody supplementation test positive or nucleic acid qualitative test positive or nucleic acid quantification>5000 copies/mL);
  • ② Has a history of epidemiology or clinical manifestations related to AIDS, tested positive for HIV nucleic acid twice;
  • ③ HIV isolation test positive;
  • Receive treatment at the hospital participating in the study; Age range: 18-80 years old, male or female not limited;
  • Patients who are willing to participate in this clinical study and sign the informed consent form for this study.

排除标准

  • Individuals who meet any of the following criteria are not eligible to participate in this study:
  • Pregnant or lactating women; Men and women who are preparing for natural conception or artificial assisted reproduction;
  • Severe aphasia, physical disability, or any other non neuropsychological factors that may hinder the completion of the assessment;
  • is currently involved in other research;
  • Having a tendency towards violence may endanger the safety of others.

研究组 & 干预措施

Group INSTI

Treated by INSTI

干预措施: All kinds of INSTI medications (Drug)

Group CONV

Treated by Conventional medicines

干预措施: All kinds of conventional medications (Drug)

结局指标

主要结局

The prevalence of AO among different treatment strategies

时间窗: 2025.8-2026.7

Observe the differences in the prevalence of AO in PLWH under different treatment strategies

次要结局

  • The changes of Poor EM after the treatment of newly diagnosed PLWH(2025.8-2026.7)

研究者

申办方类型
Other
责任方
Sponsor

相似试验